Skip to main navigation
  Menu

ASLAN Pharmaceuticals

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
EN
english中文

Investor Relations

Investor Relations

  • Investor Home
  • Corporate Information
  • Stock Information
  • News & Events
  • Financial Information
  • Shareholder Services
    • Delisting from TPEx
    • Investor FAQs
    • Information Request
    • Email Alerts
    • IR Contacts

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Alerts sign up

Required fields denoted by an asterisk ().
Alert type

Delisting from Taipei Exchange (TPEx) and Conversion of TPEx shares to ADS

Delisting from Taipei Exchange (TPEx) and Conversion of TPEx shares to ADS

For holders of US ADS:
Frequently Asked Questions
For holders of TPEx ordinary shares:
Frequently Asked Questions 10.5 KB
Conversion Forms 10.5 KB
Conversion Forms (Example) 10.5 KB
 
 

Shareholder Tools

  • Print Page

    Print Page

  • RSS Feeds

    RSS Feeds

  • E-mail Alerts

    E-mail Alerts

Company

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
  • Terms and Conditions

Careers

For more information on employment opportunities at ASLAN, please contact us at careers@aslanpharma.com

Contact Us

Singapore Headquarters
83 Clemenceau Avenue
#12-03 UE Square
Singapore 239920
Tel: +65 6222 4235
Fax: +65 6225 2419

contact@aslanpharma.com